unknown by Anthony Amoroso
BioMed Central
Page 1 of 1
(page number not for citation purposes)
Retrovirology
Open AccessOral presentation
yesThe Complexities of ART Which Prevent Durable Viral 
Suppression
Anthony Amoroso*‡
Address: Institute of Human Virology
Email: Anthony Amoroso* - amoroso@umbi.umd.edu
* Corresponding author    ‡Presenting author    
The complexities of ART which prevent durable viral sup-
pression should not be under estimated, and include the
need for absolute adherence, the rapid development of
resistance, and the impact of cross resistance, unequal
potency of ARV's, pharmacokinetic limitations, and drug
toxicities. Providers of HIV care in the U.S. are faced with
the increased complexities of care as they encounter grow-
ing numbers of patients with drug resistance. Reliance on
frequent use of viral load monitoring and genotypic anal-
ysis has become the recommended norms.
As the world prepares for antiretroviral scale up programs
in resource limited nations, the need to achieve durable
antiretroviral therapy (ART) success across multiple differ-
ent patient populations and to decrease the reliance on
frequent viral loads and genotypes to gauge treatment out-
comes has become more apparent. Treatment programs in
clinics which serve patients in resource limited settings are
trying to address these complexities to improve long term
treatment success.
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